Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Oslo University Hospital
With
Maria Sklodowska-Curie National Research Institute of Oncology
Erasmus Medical Center
Landspitali University Hospital
Uppsala University Hospital
Karolinska Institutet
Memorial Sloan Kettering Cancer Center
Harvard School of Public Health (HSPH)
Age
55–64
Sex
ALL
Healthy volunteers
Accepted
You may be eligible if
This study is a population-based randomised controlled trial, with randomisation of individuals age 55-64 years living in the screening areas directly from the Population Registries to either screening group or control group. Eligible persons with the same home address will be randomised to the same group (household randomisation).
You may not be if
Individuals with previous colorectal surgery (resections, enterostomies)
Individuals in need of long-lasting attention and nursing services (somatic or psychosocial, mental retardation).
On-going cytotoxic treatment or radiotherapy for malignant disease
Severe chronic (longer than trial duration) cardiac (NYHA III-IV)or lung disease
Lifelong anticoagulant therapy with Warfarin
A coronary event requiring hospitalization during the last 3 months
A cerebrovascular event during the last 3 months
Resident abroad
Return of unopened letter of invitation and/or reminder (address unknown)
Message from neighbour/family/post office on death of screenee (not updated in Population Registry)
